Camad, Baby Girl .

HRN: 21-99-68  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2022
AMPICILLIN 1GM (VIAL)
11/27/2022
12/04/2022
IV
170mg
Q12
Thickly MSAF
Waiting Final Action 
11/27/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/27/2022
12/04/2022
IV
51mg
OD
Thickly MSAF
Waiting Final Action 
11/27/2022
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
11/27/2022
11/27/2022
EYE
0.5%
Now
Eye Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: